The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B

This publication has 20 references indexed in Scilit:

• Long-term therapy of chronic hepatitis B with lamivudine
  Hepatology, 2000
• Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
  Hepatology, 1999
• Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu
  Liver Transplantation and Surgery, 1999
• Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under hbig immunoglobulin after liver transplantation
  Hepatology, 1999
• Biphasic Clearance Kinetics of Hepatitis B Virus From Patients During Adefovir Dipivoxil Therapy
  Hepatology, 1999
• Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver Transplantation
  Hepatology, 1999
• Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
  Journal of Clinical Investigation, 1998
• Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy
  Hepatology, 1998
• HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
  Science, 1996
• A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1991